Cross Country Healthcare (CCRN) Tops Q4 EPS by 2c; offers guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of $0.29, $0.02 better than the analyst estimate of $0.27. Revenue for the quarter came in at $414.04 million versus the consensus estimate of $404.42 million.

GUIDANCE:

Cross Country Healthcare sees Q1 2024 EPS of $0.15-$0.25, versus the consensus of $0.30. Cross Country Healthcare sees Q1 2024 revenue of $370-380 million, versus the consensus of $399 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• SpaceX receives Baa1 rating from Moody's with stable outlook
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral